Blog

113 Articles

microbubbles
Research
April 19, 2024 • 2 Min

Using Ultrasound to Enhance the Effectiveness of Chemotherapy

A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.

Dr. Kelsey Klute
Research
April 3, 2024 • 6 Min

Slowing the Growth of One Type of Advanced Neuroendocrine Tumor

Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.

Dr. Allyson Ocean
Research
March 25, 2024 • 3 Min

Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients

Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.

Sapna Syngal
Research
March 20, 2024 • 5 Min

For Families at Risk, Remote Education May Be Key in Improving Genetic Testing Uptake

What’s the best way to educate families at risk for pancreatic cancer about genetic testing? Dr. Sapna Syngal discusses the results of the GENERATE study.

Dr. Elizabeth Jaffee
Research
March 6, 2024 • 5 Min

Platform Trial Increases Efficiency in Studying Immunotherapy

Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.

Dr. Gulam Manji
Research
February 23, 2024 • 5 Min

Chemotherapy Plus Immunotherapy Trial Shows Promise

Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.

Laboratory at the NIH
News
February 14, 2024 • 3 Min

New FDA Approval Brings More Treatment Options in Metastatic Disease

The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.

Pancreatic cancer researcher Dr. Shubham Pant
Research
February 9, 2024 • 5 Min

New Vaccine Harnesses Power Of the Lymph Nodes

A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.

long-term survivor Davi D'Agostino
Survivor Stories
January 19, 2024 • 1 Min

Steely Strength to Keep Going

Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.

slide of pancreatic cancer
Research
January 5, 2024 • 2 Min

Treating High Blood Sugar in People With Pancreatic Cancer

A new clinical trial explores the effectiveness of the drug glipizide in controlling high blood sugar in pancreatic cancer patients.

researcher Herve Tiriac
Research
November 20, 2023 • 4 Min

Two-Drug Combo Targets KRAS and Fights Resistance

Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.

Lab worker working on immunotherapy
Clinical Trials
November 7, 2023 • 2 Min

A New Approach to Immunotherapy for Advanced Pancreatic Cancer

Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.

Dr. Anup Kasi
Chemotherapy
October 25, 2023 • 3 Min

Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer

With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.

Radiation Whole Abdomen
Research
September 21, 2023 • 2 Min

Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer

In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.

Dr. Vinod Balachandran
Research
September 5, 2023 • 3 Min

Phase II mRNA Vaccine Trial Opens

The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.